Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Neuroma 1Gastroparesis 1Esophageal Motility Disorders 1Esophageal Diseases 1Esophageal Achalasia 1Chronic Pain 1Breast Neoplasms 1Agnosia 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Botulinum Toxins, Type A × 1 year × Clear all
NCT07624877 2026-06-03

IN-PERI NEUROM

Ukrainian Society of Regional Anesthesia and Pain Therapy

Phase NA Not yet recruiting
100 enrolled

Neuroma, Chronic Pain

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting
123 enrolled
Breast

Agnosia, Breast Neoplasms

NCT06721520 2026-02-25

EMPTY

The Cleveland Clinic

Phase 2/3 Recruiting
170 enrolled
Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Motility Disorders, Gastroparesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡